Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News SCCT 2023

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

Todd Neale

August 08, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

L.A. McKeown

March 06, 2023

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News AHA 2020

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

Shelley Wood

November 14, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Daily News

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

L.A. McKeown

December 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

News Daily News

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

August 24, 2011

Advertisement

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Chest Pain, High Troponin, and Clear Coronaries: Is CMR Needed?

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

TCTMD’s Top 10 Most Popular Stories for August 2018

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

Live From Denver: TCT 2017, Day Three

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content